UA86802C2 - Комбинация симетикона и бисакодила для предрасположенных к запору пациентов, которые страдают от ощущения вздутия живота - Google Patents

Комбинация симетикона и бисакодила для предрасположенных к запору пациентов, которые страдают от ощущения вздутия живота

Info

Publication number
UA86802C2
UA86802C2 UAA200611802A UAA200611802A UA86802C2 UA 86802 C2 UA86802 C2 UA 86802C2 UA A200611802 A UAA200611802 A UA A200611802A UA A200611802 A UAA200611802 A UA A200611802A UA 86802 C2 UA86802 C2 UA 86802C2
Authority
UA
Ukraine
Prior art keywords
simethicone
bisacodyl
combination
patients suffering
bloated feeling
Prior art date
Application number
UAA200611802A
Other languages
English (en)
Ukrainian (uk)
Inventor
Мартина Грипп
Кристоффель Шуийт
Original Assignee
Бёрингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бёрингер Ингельхайм Интернациональ Гмбх filed Critical Бёрингер Ингельхайм Интернациональ Гмбх
Publication of UA86802C2 publication Critical patent/UA86802C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение касается применения симетикона и бисакодила для приготовления лекарственного средства, предназначенного для лечения предрасположенных к запорам индивидуумов, которые страдают от ощущения вздутия живота на протяжении ночи.
UAA200611802A 2004-04-13 2005-04-12 Комбинация симетикона и бисакодила для предрасположенных к запору пациентов, которые страдают от ощущения вздутия живота UA86802C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04008736 2004-04-13

Publications (1)

Publication Number Publication Date
UA86802C2 true UA86802C2 (ru) 2009-05-25

Family

ID=34924581

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200611802A UA86802C2 (ru) 2004-04-13 2005-04-12 Комбинация симетикона и бисакодила для предрасположенных к запору пациентов, которые страдают от ощущения вздутия живота

Country Status (8)

Country Link
US (2) US20070281905A1 (ru)
EP (1) EP1737537A1 (ru)
JP (2) JP2008503445A (ru)
BR (1) BRPI0509861A (ru)
CA (1) CA2559239C (ru)
RU (1) RU2384339C2 (ru)
UA (1) UA86802C2 (ru)
WO (1) WO2005099821A1 (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007015982A (ja) * 2005-07-07 2007-01-25 Tendou Seiyaku Kk 緩下剤
DE102006001199A1 (de) * 2006-01-10 2007-07-12 Medicoforum Gmbh Fixe Kombination von Substanzen unter Beigabe von Entschäumern zum Einsatz als Darmspüllösung und/oder Laxans
WO2009036906A1 (de) * 2007-09-22 2009-03-26 Bayer Consumer Care Ag Zusammensetzung mit wirkstoffkombination aus einem laxans und einem entschäumer zur behandlung von obstipation
IT1405757B1 (it) * 2010-11-03 2014-01-24 Gruppo Farmaimpresa Srl Preparazione farmaceutica comprendente saccaromyces e simeticone per il trattamento delle patologie gastrointestinali
BR112013014827A2 (pt) * 2010-12-13 2016-10-04 Antony Wettstein formulações gástricas e colônicas e métodos para produzir e usar as mesmas
EP2877163B1 (en) 2012-07-27 2019-03-20 Redhill Biopharma Ltd. Formulations and methods of manufacturing formulations for use in colonic evacuation
DE102012024434A1 (de) 2012-12-14 2014-06-18 Regalismons S.A. Verstärkung der entschäumenden Wirkung von Polysiloxanen, zugehöriger Zusammensetzungen und Lösungen
WO2014189933A1 (en) * 2013-05-22 2014-11-27 Empire Technology Development Llc Long delayed release laxative
US20190021992A1 (en) * 2016-01-13 2019-01-24 Johnson & Johnson Consumer Inc. New improved composition comprising at least one cadotril
DK3586832T3 (da) 2018-06-28 2021-04-06 Synformulas Gmbh Farmaceutisk sammensætning til behandlingen af forstoppelse

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6150919A (ja) * 1984-08-20 1986-03-13 Tenkoushiya:Kk 人間及び動物用の便秘解消剤
DE4341165C1 (de) * 1993-12-02 1995-04-20 Upmeyer Hans Juergen Verwendung von Dimeticon zur Behandlung von Obstipation
JPH07242557A (ja) * 1994-03-03 1995-09-19 Ss Pharmaceut Co Ltd 乳酸菌含有瀉下薬組成物
CN1288730A (zh) * 1999-09-07 2001-03-28 麦克内尔-Ppc股份有限公司 轻泻组合物
JP2002003388A (ja) * 2000-06-20 2002-01-09 Nof Corp 便秘解消剤組成物
JP2002003377A (ja) * 2000-06-20 2002-01-09 Taisho Pharmaceut Co Ltd ピコスルファートナトリウム配合緩下剤
US6622856B2 (en) * 2001-04-25 2003-09-23 Johnson & Johnson Consumer Companies, Inc. Relief kit
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
WO2009036906A1 (de) * 2007-09-22 2009-03-26 Bayer Consumer Care Ag Zusammensetzung mit wirkstoffkombination aus einem laxans und einem entschäumer zur behandlung von obstipation

Also Published As

Publication number Publication date
RU2384339C2 (ru) 2010-03-20
RU2006139819A (ru) 2008-05-20
US20070281905A1 (en) 2007-12-06
WO2005099821A1 (en) 2005-10-27
CA2559239C (en) 2021-04-06
BRPI0509861A (pt) 2007-10-16
US20120309715A1 (en) 2012-12-06
EP1737537A1 (en) 2007-01-03
JP2013010783A (ja) 2013-01-17
JP2008503445A (ja) 2008-02-07
CA2559239A1 (en) 2005-10-27

Similar Documents

Publication Publication Date Title
UA86802C2 (ru) Комбинация симетикона и бисакодила для предрасположенных к запору пациентов, которые страдают от ощущения вздутия живота
MXPA04003666A (es) Uso de flibanserina para tratamiento de trastornos sexuales.
AU2003210300A1 (en) The use of tnf-alpha antagonist as drugs for the treatment of patients with sepsis and without suffering from total organ failure
WO2004043341A3 (en) Treatment for hemorrhagic shock
HK1064921A1 (en) Sustained release formulations of oxymorphone
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
TWI372056B (en) Novel medicament combinations for the treatment of respiratory diseases
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
WO2006053049A3 (en) Herbal composition phy906 and its use in chemotherapy
IL178827A0 (en) Use of reboxetine for the treatment of pain
ZA200303037B (en) Herbal pharmaceutical composition for treatment of HIV/Aids patients.
WO2007081486A3 (en) Oral administration of defensins to treat intestinal diseases
HK1081861A1 (en) New synergistic combination comprising roflumilast and formoterol
WO2004073615A8 (en) Deazaflavin compounds and methods of use thereof
UA91694C2 (ru) Применение эмодепсида и pf1022a для предотвращения вертикальных эндопаразитарных инфекций
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
SG160197A1 (en) Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
EE200100689A (et) IL6RIL6 kimääri kasutamine ravimi valmistamiseks,mis on ette nähtud neuroloogiliste haiguste ravimiseks, ning farmatseutiline kompositsioon
HK1073779A1 (en) The use of darifenacin and the salt thereof
EA200801890A1 (ru) Средство для лечения шума в ушах
WO2002069944A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und nk1-rezeptor-antagonisten
HUP0103017A3 (en) Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
WO2004080450A3 (en) Combined use of a fibrate and orlistat for the treatment of obesity
EP1370697A4 (en) PEROXYREDOXIN-BASED MEDICINAL PRODUCTS FOR THE TREATMENT OF HIV-1 INFECTIONS AND METHODS OF USE
WO2004012732A3 (en) Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy